Alvogen, Inc.
UnclaimedPharmaceutical Preparation ManufacturingMorristown, NJ
Founded
2020
Primary NAICS
325412
CAGE code
6K8D6
Federal awards
$308.6M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Defense | $94 | 3 |
| 2026 | Department of Veterans Affairs | $0 | 6 |
| 2025 | Department of Health and Human Services | $227,679,090 | 2 |
| 2025 | Department of Defense | $1,513 | 5 |
| 2025 | Department of Veterans Affairs | $0 | 6 |
| 2024 | Department of Health and Human Services | $57,099,989 | 4 |
| 2024 | Department of Defense | $1,446 | 1 |
| 2024 | Department of Veterans Affairs | $0 | 10 |
| 2023 | Department of Health and Human Services | $5,999,992 | 1 |
| 2023 | Department of Veterans Affairs | $0 | 6 |
| 2023 | Department of Defense | -$27,918 | 22 |
| 2022 | Department of Health and Human Services | $17,815,000 | 2 |
| 2022 | Department of Defense | $7,546 | 64 |
| 2022 | Department of Veterans Affairs | $0 | 14 |